AU Patent

AU2022209242A1 — Methods for photodynamic therapy

Assigned to Sun Pharmaceutical Industries Inc · Expires 2022-08-18 · 4y expired

What this patent protects

A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to …

USPTO Abstract

A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to the treatment area, covering the treatment area with a low-density polyethylene barrier. The treatment area is covered with the low-density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area. 10988386_1 (GHMatters) P110419.AU

Drugs covered by this patent

Patent Metadata

Patent number
AU2022209242A1
Jurisdiction
AU
Classification
—
Expires
2022-08-18
Drug substance claim
No
Drug product claim
No
Assignee
Sun Pharmaceutical Industries Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.